| Description | BMD4503-2 is an LRP5/6-sclerostin interaction inhibitor. BMD4503-2 recovers the downregulated activity of the Wnt/β-catenin signaling pathway by competitively binding to the LRP5/6-sclerostin complex. |
| molecular weight | 483.54 |
| Molecular formula | C26H21N5O3S |
| CAS | 301357-87-9 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year |